Interestingly, downregulation of PTEN by siPTEN suppressed the effects of miR-21 antagomir on EMT and CSC phenotype, confirming that PTEN is a target of miR-21 during reversal of EMT and CSC phenotype in breast cancer cells [77]. The gene discussed is PTEN; the disease is breast carcinoma.